DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
34 hedge funds and large institutions have $1.98M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
34
Holding in Top 10
–
Calls
$130K
Puts
–
Top Buyers
| 1 | +$265K | |
| 2 | +$135K | |
| 3 | +$27.6K | |
| 4 |
CAC
Cowen and Company
New York
|
+$17.6K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$6.55K |
Top Sellers
| 1 | -$115K | |
| 2 | -$107K | |
| 3 | -$28.7K | |
| 4 |
VF
Virtu Financial
New York
|
-$4K |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
-$1.8K |